BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 20448111)

  • 1. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.
    Iwanaga M; Watanabe T; Utsunomiya A; Okayama A; Uchimaru K; Koh KR; Ogata M; Kikuchi H; Sagara Y; Uozumi K; Mochizuki M; Tsukasaki K; Saburi Y; Yamamura M; Tanaka J; Moriuchi Y; Hino S; Kamihira S; Yamaguchi K;
    Blood; 2010 Aug; 116(8):1211-9. PubMed ID: 20448111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count.
    Kamihira S; Dateki N; Sugahara K; Hayashi T; Harasawa H; Minami S; Hirakata Y; Yamada Y
    Clin Lab Haematol; 2003 Apr; 25(2):111-7. PubMed ID: 12641615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating mRNA expression of tax, B chain of PDGF and PDGF-β receptors as well as HTLV-I proviral load in ATL patients and healthy carriers.
    Atabati H; Esmaeili SA; Allahyari A; Shirdel A; Rahimi H; Rezaee SA; Momtazi-Borojeni AA; Rafatpanah H
    J Med Virol; 2021 Jun; 93(6):3865-3870. PubMed ID: 32918495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.
    Manns A; Miley WJ; Wilks RJ; Morgan OS; Hanchard B; Wharfe G; Cranston B; Maloney E; Welles SL; Blattner WA; Waters D
    J Infect Dis; 1999 Nov; 180(5):1487-93. PubMed ID: 10515807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of HTLV-1 proviral load (PVL) and antibody detected with various kinds of tests in Japanese blood donors to understand the relationship between PVL and antibody level and to gain insights toward better antibody testing.
    Matsumoto C; Sagara Y; Sobata R; Inoue Y; Morita M; Uchida S; Kiyokawa H; Satake M; Tadokoro K
    J Med Virol; 2017 Aug; 89(8):1469-1476. PubMed ID: 28252206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HTLV-1 proviral DNA in cell-free DNA: Potential for non-invasive monitoring of Adult T cell leukaemia/lymphoma using liquid biopsy?
    Joris T; Haddow J; Taylor GP; Cook LBM; Rowan AG
    Front Immunol; 2023; 14():1150285. PubMed ID: 37114063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Soluble CD30 as a Possible Marker of Adult T-cell Leukemia in HTLV-1 Carriers: a Nested Case-Control Study.
    Takemoto S; Iwanaga M; Sagara Y; Watanabe T
    Asian Pac J Cancer Prev; 2015; 16(18):8253-8. PubMed ID: 26745069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-lymphotropic virus type I proviral loads in patients with adult T-cell leukemia-lymphoma: Comparison between cutaneous type and other subtypes.
    Yonekura K; Utsunomiya A; Seto M; Takatsuka Y; Takeuchi S; Tokunaga M; Kubota A; Takeda K; Kanzaki T; Uchida Y; Kawai K; Kanekura T
    J Dermatol; 2015 Dec; 42(12):1143-8. PubMed ID: 26134467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.
    Furtado Mdos S; Andrade RG; Romanelli LC; Ribeiro MA; Ribas JG; Torres EB; Barbosa-Stancioli EF; Proietti AB; Martins ML
    J Med Virol; 2012 Apr; 84(4):664-71. PubMed ID: 22337307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proviral loads of human T-lymphotropic virus Type 1 in asymptomatic carriers with different infection routes.
    Ueno S; Umeki K; Takajo I; Nagatomo Y; Kusumoto N; Umekita K; Morishita K; Okayama A
    Int J Cancer; 2012 May; 130(10):2318-26. PubMed ID: 21780105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and human T-cell leukemia virus type-1 (HTLV-1) proviral load in HTLV-1-positive patients with rheumatoid arthritis: Baseline data in a single center cohort study.
    Eguchi K; Iwanaga M; Terada K; Aramaki T; Tuji Y; Kurushima S; Kojima K; Arima K; Iwamoto N; Ichinose K; Kawakami A; Hirakata N; Ueki Y
    Mod Rheumatol; 2020 May; 30(3):471-480. PubMed ID: 30938551
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantification of proviral DNA load in human T-cell leukaemia virus type I infections.
    Tosswill JH; Taylor GP; Clewley JP; Weber JN
    J Virol Methods; 1998 Nov; 75(1):21-6. PubMed ID: 9820571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.
    Césaire R; Dehée A; Lézin A; Désiré N; Bourdonné O; Dantin F; Béra O; Smadja D; Abel S; Cabié A; Sobesky G; Nicolas JC
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):799-805. PubMed ID: 11429121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.
    Hisada M; Okayama A; Shioiri S; Spiegelman DL; Stuver SO; Mueller NE
    Blood; 1998 Nov; 92(10):3557-61. PubMed ID: 9808547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry.
    Lee TH; Chafets DM; Busch MP; Murphy EL
    J Clin Virol; 2004 Dec; 31(4):275-82. PubMed ID: 15494269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type 1 carriers in Japan.
    Satake M; Yamada Y; Atogami S; Yamaguchi K
    Leuk Lymphoma; 2015 Jun; 56(6):1806-12. PubMed ID: 25219595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry.
    Kobayashi S; Watanabe E; Ishigaki T; Ohno N; Yuji K; Nakano K; Yamochi T; Watanabe N; Tojo A; Watanabe T; Uchimaru K
    Cancer Sci; 2015 May; 106(5):598-603. PubMed ID: 25703103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral health profile in patients infected with HTLV-1: clinical findings, proviral load, and molecular analysis from HTLV-1 in saliva.
    Lins L; de Carvalho VJ; de Almeida Rego FF; Azevedo R; Kashima S; Gallazi VN; Xavier MT; Galvão-Castro B; Alcantara LC
    J Med Virol; 2012 Sep; 84(9):1428-36. PubMed ID: 22825822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective human T-lymphotropic virus type 1 provirus in asymptomatic carriers.
    Takenouchi H; Umeki K; Sasaki D; Yamamoto I; Nomura H; Takajo I; Ueno S; Umekita K; Kamihira S; Morishita K; Okayama A
    Int J Cancer; 2011 Mar; 128(6):1335-43. PubMed ID: 20473938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.